Biocure Technology Corp Announces a MOU with the Government of Uzbekistan and GoldDream LLC to Build a Manufacturing Plant to Produce Biosimilars

Biocure Technology Corp Announces a MOU with the Government of Uzbekistan and Gold-Dream LLC to Build a Manufacturing Plant to Produce Biosimilars

Biocure Technology Corp. (CSE:CURE) (OTCQB:BICTF) ("CURE" or the "Company") BiocurePharm, Korea ("BPK"), a wholly owned subsidiary of Biocure Technology Inc. ("CURE") has entered into a Memorandum of Understanding with the Agency of Development of the Pharmaceutical Industry under the Ministry of Health, The Republic of Uzbekistan (herein after called "MHU") and Gold-Dream LLC (herein after called "GDL") on Feb 15th, 2019 in Korea.

More From BioPortfolio on "Biocure Technology Corp Announces a MOU with the Government of Uzbekistan and Gold-Dream LLC to Build a Manufacturing Plant to Produce Biosimilars"